The NP Medical In-line Back Check Valve is a time proven design used in IV delivery devices including gravity and pump sets. Its unique properties provide consistent opening pressure and flow characteristics for demanding medical applications.

The robust design makes the In-line a superior choice for various medical applications. Its round profile is compatible with automated set assembly equipment.

The valve features a preloaded, normally closed latex free silicone diaphragm that allows flow in one direction while checking flow in the opposite direction. It is composed of a sonically bonded, DEHP free, thermoplastic body and an elastomeric diaphragm. All materials are USP Class VI approved.

Needle-free access valves for infusion or aspiration

The NP Medical Luer Activated Valve Plus (LAV+) features a normally closed silicone diaphragm that checks flow until mechanically opened with a luer.The needle free design protects both patient and clinician.

The enhanced two-way design of the LAV+ is compatible with various drugs and blood products. Its unique geometry allows for infusion or aspiration. The valve features a castellated actuator which provides a flow pattern that allows for complete flushing of blood and other viscous drugs.

The LAV+ is composed if a sonically welded, DEHP free, thermoplastic body, a latex free silicone diaphragm and a green actuator/plunger. All materials are USP Class VI approved.

The NP Medical Pressure Activated Valve (PAV) is designed to be used as a "One-Way" valve for drug delivery and as an "Anti-Siphon" valve for pump applications.The low priming valve yields stable cracking pressure for dispensing anesthetic drugs as well as for use with other IV drug delivery devices.

The PAV features a preloaded normally closed silicone diaphragm that allows flow in one direction while checking flow in the opposite direction, preventing retrograde flow. The valve is composed of a sonically welded, DEHP free, thermoplastic body and a latex free, silicone diaphragm.

The valve is composed of a sonically welded, DEHP free, thermoplastic body and a latex free, silicone diaphragm. All materials are USP, Class VI approved.

The Nutrivex™ unit houses a 1.2 µm, PES membrane for the quantitative removal of Candida albicans and employs a PVDF hydrophobic vent for reliable air elimination.

The filter unit is comprised of a hydrophilic 1.2 µm polyethersulfone (PES) primary membrane and a 0.1 µm hydrophobic PVDF, vent membrane. The housing, with a yellow core and a clear sleeve, is manufactured from Eastar DN003, a co-polyester. All materials meet ISO 10993 requirements for external communicating devices, blood path indirect, and for contact durations of 24 hours or less.

The Microvex™ IV filter unit with low priming and hold-up volume (< 0.4 mL) is ideal for neonatal therapies, alternative site infusion therapies, low-volume chemotherapeutics or antibiotic infusion.The unit can be used in conjunction with both gravity and pump feeds.

The Microvex™ filter is comprised of a hydrophilic 0.22 µm, polyethersulfone (PES) primary membrane and a 0.1 µm PVDF, hydrophobic vent membrane within a Cyrolite G20 acrylic housing. All materials meet ISO 10993 requirements for external communicating devices, blood path indirect, and for contact durations of 24 hours or less.

The Nutrivex™ unit houses a 1.2 µm, PES membrane for the quantitative removal of Candida albicans and employs a PVDF hydrophobic vent for reliable air elimination.

The filter unit is comprised of a hydrophilic 1.2 µm polyethersulfone (PES) primary membrane and a 0.1 µm hydrophobic PVDF, vent membrane. The housing, with a yellow core and a clear sleeve, is manufactured from Eastar DN003, a co-polyester. All materials meet ISO 10993 requirements for external communicating devices, blood path indirect, and for contact durations of 24 hours or less.

The Microvex™ IV filter unit with low priming and hold-up volume (< 0.4 mL) is ideal for neonatal therapies, alternative site infusion therapies, low-volume chemotherapeutics or antibiotic infusion.The unit can be used in conjunction with both gravity and pump feeds.

The Microvex™ filter is comprised of a hydrophilic 0.22 µm, polyethersulfone (PES) primary membrane and a 0.1 µm PVDF, hydrophobic vent membrane within a Cyrolite G20 acrylic housing. All materials meet ISO 10993 requirements for external communicating devices, blood path indirect, and for contact durations of 24 hours or less.

The Nutrivex™ unit houses a 1.2 µm, PES membrane for the quantitative removal of Candida albicans and employs a PVDF hydrophobic vent for reliable air elimination.

The filter unit is comprised of a hydrophilic 1.2 µm polyethersulfone (PES) primary membrane and a 0.1 µm hydrophobic PVDF, vent membrane. The housing, with a yellow core and a clear sleeve, is manufactured from Eastar DN003, a co-polyester. All materials meet ISO 10993 requirements for external communicating devices, blood path indirect, and for contact durations of 24 hours or less.

The Microvex™ IV filter unit with low priming and hold-up volume (< 0.4 mL) is ideal for neonatal therapies, alternative site infusion therapies, low-volume chemotherapeutics or antibiotic infusion.The unit can be used in conjunction with both gravity and pump feeds.

The Microvex™ filter is comprised of a hydrophilic 0.22 µm, polyethersulfone (PES) primary membrane and a 0.1 µm PVDF, hydrophobic vent membrane within a Cyrolite G20 acrylic housing. All materials meet ISO 10993 requirements for external communicating devices, blood path indirect, and for contact durations of 24 hours or less.